| | Schwind, Ziemer form marketing alliance
| | Schwind eye-tech-solutions and Ziemer Ophthalmic solutions have formed a marketing alliance to offer an integrated system featuring their lasers for refractive surgeons performing all-laser LASIK. | |  |
|
|
| Understanding corneal hysteresis fundamental in grasping biomechanics concepts
| Can clinicians get more information out of measurements? Further research needed
| | Ophthalmology Times | | Daniel S. Durrie, MD, explains corneal hysteresis as measured with the Ocular Response Analyzer (ORA, Reichert) and why he believes further research with the ORA may enhance understanding of corneal biomechanics. |
| | | Screening not foolproof for avoiding post-LASIK ectasia
| Some patients genetically predisposed to develop complication, study shows
| | Ophthalmology Times | | Several preoperative features have been identified as important risk factors for ectasia after laser refractive surgery, particularly in patients undergoing LASIK for high myopia or myopic astigmatism. This complication can occur in the absence of any of these findings, however. |
| | Confocal microscopy yields higher-resolution images
| Technology can be used for refractive surgery, also beneficial in assessing dry eye after procedure
| | Ophthalmology Times | | Confocal microscopy can be used for refractive surgery to address concerns regarding wound healing and the interface, especially when assessing different techniques. The technology also can be used to assess problems after LASIK regarding dry eye. |
| | Instrument analyzes biomechanical function of tissue
| Curve analysis, refinements of system needed in future, physician suggests
| | Ophthalmology Times | | Proprietary instrumentation (Ocular Response Analyzer, Reichert Ophthalmic Instruments) is useful in ophthalmology, but the current generation of the instrument may have some limitations, according to one physician. |
|
| Beyond anti-VEGF: Investigative drugs, approaches abound
| | Ophthalmology Times | | Drugs are under development and in clinical trials that can complement anti-vascular endothelial growth factor drugs (VEGF) and attack age-related macular degeneration in ways that differ from the anti-VEGF approach. If these prove successful, many more patients can benefit from therapy for AMD. |
| | Schwind, Ziemer form marketing alliance
| | Ophthalmology Times E-News | | Schwind eye-tech-solutions and Ziemer Ophthalmic solutions have formed a marketing alliance to offer an integrated system featuring their lasers for refractive surgeons performing all-laser LASIK. |
| | | ESCRS: Femtosecond to fully replace microkeratome
| |
Ophthalmology Times Meeting E-News | | The age of microkeratomes is coming to an end as femtosecond lasers come of age. That's the chief conclusion drawn by Dr Gunther Grabner, professor of ophthalmology at the Paracelsus University of Salzburg, in a survey on the advantages and limitations of femtosecond lasers. |
| | ESCRS: FLEx: just as effective but cheaper than Femto-LASIK
| | Ophthalmology Times Meeting E-News | | Refractive outcomes for Femtosecond Lenticule Extraction (FLEx) are getting close to those of eximer-based Femto-LASIK, and patients are expressing high degrees of satisfaction with both techniques, Dr Walter Sekundo told delegates at a session on current trends in laser refractive surgery. |
|
| 
